Hyperlipidemia after cardiac transplantation: Be aware and possibly wary of drug therapy for lowering of serum lipids
- 31 May 1991
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 121 (5) , 1585-1590
- https://doi.org/10.1016/0002-8703(91)90180-p
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Angiographic implications of cardiac transplantationThe American Journal of Cardiology, 1989
- Lovastatin therapy for hypercholesterolemia in cardiac transplant recipientsThe American Journal of Cardiology, 1989
- Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infectionThe American Journal of Cardiology, 1989
- Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantationThe American Journal of Cardiology, 1989
- Retransplantation for severe accelerated coronary artery disease in heart transplant recipientsThe American Journal of Cardiology, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Association of Serum Lipids, Lipoproteins, and Apolipoproteins with Coronary Artery Disease Assessed by Coronary ArteriographyAnnals of the New York Academy of Sciences, 1985
- Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacinMetabolism, 1985